Catherine Weng, MD
Facial Plastic Surgery · Wayne, PANPI 1093030926
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by AbbVie at 47.2% of the total.
Across 27 payments — averaging $28.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$367
- Merz North America, Inc.$143
- Optinose US, Inc.$77
- Acclarent, Inc$45
- Galderma Laboratories, L.p.$27
- Stryker$25
- plus $94 from 6 others
What the payments were for
- Food & beverage$778100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 10 | $367 |
| Merz North America, Inc. | 2 | $143 |
| Optinose US, Inc. | 4 | $77 |
| Acclarent, Inc | 2 | $45 |
| Galderma Laboratories, L.p. | 2 | $27 |
| Stryker | 1 | $25 |
| Novartis | 1 | $21 |
| Sanofi | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $14 |
| Cook Medical LLC | 1 | $14 |
| Integra Lifesciences Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few facial plastic surgery providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 64 | $880 |
| Omeprazole | 48 | $704 |
| Ipratropium Bromide | 24 | $688 |
| Azelastine Hcl | 35 | $661 |
| Famotidine | 32 | $303 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $181 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 15 | $160 |
| Chlorhexidine Gluconate | 11 | $36 |
Paid to pharmacies, not to this prescriber.
Other facial plastic surgery in Wayne
- Scott GaynerHarrisburg$31K
- Kirk SteehlerErie$3K
- Stephen SchellErie$2K
- Robert ChiuPittsburgh$1K
- Christopher HovePaoli$926
- Christina YverPittsburgh$607
- Sinehan BayrakWest Chester$593
- Edgar del Toro DiezHershey$464
- Rahul NaiduLatrobe$435
- Hilary SalesElkins Park$250
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.